Matrix Metalloproteinase-1 Polymorphism (-1607G) and Disease Severity in Non-Cystic Fibrosis Bronchiectasis in Taiwan

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Hsieh, Meng Heng ^a   Chou, Pai Chien ^a   Chou, Chun Liang ^a   Ho, Shu Chuan ^a,b   Joa, Wen Ching ^a   Chen, Li Fei ^a   Sheng, Te Fang ^a   Lin, Horng Chyuan ^a   Wang, Tsai Yu ^a   Chang, Po Jui ^a   Wang, Chun Hua ^a   Kuo, Han Pin ^a  

^a Chang Gung Medical Center   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME PRECURSOR; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE 1 PRECURSOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRONCHIECTASIS; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; ENZYME REGULATION; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HOSPITALIZATION; HUMAN; HUMAN CELL; LUNG FIBROSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; MONOCYTE; NON CYSTIC FIBROSIS BRONCHIECTASIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; RESPIRATORY TRACT DISEASE; TAIWAN; VULNERABLE POPULATION;

ALLELES; BRONCHIECTASIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN;

EID: 84878828991     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066265     Document Type: Article

References (44)

1. Cole PJ (1986) Inflammation: a two-edged sword-the model of bronchiectasis. Eur J Respir Dis Suppl 147: 6-15.
2. Keistinen T, Saynajakangas O, Tuuponen T, Kivela SL, (1997) Bronchiectasis: an orphan disease with a poorly-understood prognosis. Eur Respir J 10: 2784-2787.
3. Abdelaziz MM, Devalia JL, Khair OA, Calderon M, Sapsford RJ, et al. (1995) The effect of conditioned medium from cultured human bronchial epithelial cells on eosinophil and neutrophil chemotaxis and adherence in vitro. Am J Respir Cell Mol Biol 13: 728-737.
4. Sepper R, Konttinen YT, Sorsa T, Koski H, (1994) Gelatinolytic and type IV collagenolytic activity in bronchiectasis. Chest 106: 1129-1133.
5. Gaggar A, Jackson PL, Noerager BD, O'Reilly PJ, McQuaid DB, et al. (2008) A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J Immunol 180: 5662-5669.
6. Henry MT, McMahon K, Mackarel AJ, Prikk K, Sorsa T, et al. (2002) Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF. Eur Respir J 20: 1220-1227.
7. Parks WC, Wilson CL, Lopez-Boado YS, (2004) Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4: 617-629.
8. Campbell EJ, Cury JD, Shapiro SD, Goldberg GI, Welgus HG, (1991) Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J Immunol 146: 1286-1293.
9. Friedland JS, Shaw TC, Price NM, Dayer JM, (2002) Differential regulation of MMP-1/9 and TIMP-1 secretion in human monocytic cells in response to Mycobacterium tuberculosis. Matrix Biol 21: 103-110.
10. Wang CH, Lin HC, Lin SM, Huang CD, Liu CY, et al. (2010) MMP-1(-1607G) polymorphism as a risk factor for fibrosis after pulmonary tuberculosis in Taiwan. Int J Tuberc Lung Dis 14: 627-634.
11. Shi J, Schmitt-Talbot E, DiMattia DA, Dullea RG, (2004) The differential effects of IL-1 and TNF-alpha on proinflammatory cytokine and matrix metalloproteinase expression in human chondrosarcoma cells. Inflamm Res 53: 377-389.
12. Okuno T, Andoh A, Bamba S, Araki Y, Fujiyama Y, et al. (2002) Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts. Scand J Gastroenterol 37: 317-324.
13. Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, et al. (2003) Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature 422: 169-173.
14. Todorova L, Bjermer L, Miller-Larsson A, Westergren-Thorsson G, (2010) Relationship between matrix production by bronchial fibroblasts and lung function and AHR in asthma. Respir Med 104: 1799-1808.
15. Honda A, Abe R, Makino T, Norisugi O, Fujita Y, et al. (2008) Interleukin-1beta and macrophage migration inhibitory factor (MIF) in dermal fibroblasts mediate UVA-induced matrix metalloproteinase-1 expression. J Dermatol Sci 49: 63-72.
16. Sepper R, Konttinen YT, Ding Y, Takagi M, Sorsa T, (1995) Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease. Chest 107: 1641-1647.
17. Elkington PT, Emerson JE, Lopez-Pascua LD, O'Kane CM, Horncastle DE, et al. (2005) Mycobacterium tuberculosis up-regulates matrix metalloproteinase-1 secretion from human airway epithelial cells via a p38 MAPK switch. J Immunol 175: 5333-5340.
18. Kuo HP, Wang YM, Wang CH, He CC, Lin SM, et al. (2008) Matrix metalloproteinase-1 polymorphism in Taiwanese patients with endobronchial tuberculosis. Tuberculosis 88: 262-267.
19. Green JA, Elkington PT, Pennington CJ, Roncaroli F, Dholakia S, et al. (2010) Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and-3 expression and secretion via NF-kappaB- and Activator Protein-1-dependent monocyte networks. J Immunol 184: 6492-6503.
20. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD, (1997) Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277: 2002-2004.
21. Joos L, He JQ, Shepherdson MB, Connett JE, Anthonisen NR, et al. (2002) The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet 11: 569-576.
22. Elkington P, Shiomi T, Breen R, Nuttall RK, Ugarte-Gil CA, et al. (2011) MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J Clin Invest 121: 1827-1833.
23. Cataldo DD, Gueders M, Munaut C, Rocks N, Bartsch P, et al. (2004) Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases mRNA transcripts in the bronchial secretions of asthmatics. Lab Invest 84: 418-424.
24. Ninomiya S, Niimi T, Shimizu S, Sato S, Achiwa H, et al. (2004) Matrix metalloproteinase-1 polymorphism of promoter region in sarcoidosis and tuberculosis patients. Sarcoidosis Vasc Diffuse Lung Dis 21: 19-24.
25. Nishioka Y, Sagae S, Nishikawa A, Ishioka S, Kudo R, (2003) A relationship between Matrix metalloproteinase-1 (MMP-1) promoter polymorphism and cervical cancer progression. Cancer Lett 200: 49-55.
26. Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, et al. (1998) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58: 5321-5325.
27. Willis BC, Liebler JM, Luby-Phelps K, Nicholson AG, Crandall ED, et al. (2005) Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 166: 1321-1332.
28. Agarwal AR, Mih J, George SC, (2003) Expression of matrix proteins in an in vitro model of airway remodeling in asthma. Allergy Asthma Proc 24: 35-42.
29. Chen H, Li D, Saldeen T, Mehta JL, (2003) TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1. Am J Physiol Heart Circ Physiol 284: H1612-1617.
30. Loukides S, Bouros D, Papatheodorou G, Lachanis S, Panagou P, et al. (2002) Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest 121: 81-87.
31. Stankovic M, Nikolic A, Divac A, Rakicevic L, Tomovic A, et al. (2009) Matrix metalloproteinases gene variants in idiopathic disseminated bronchiectasis. J Investig Med 57: 500-503.
32. Dunsmore SE, Rannels DE, (1996) Extracellular matrix biology in the lung. Am J Physiol 270: L3-27.
33. Zuo F, Kaminski N, Eugui E, Allard J, Yakhini Z, et al. (2002) Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci U S A 99: 6292-6297.
34. Selman M, Ruiz V, Cabrera S, Segura L, Ramirez R, et al. (2000) TIMP-1,-2,-3, and-4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am J Physiol Lung Cell Mol Physiol 279: L562-574.
35. Tower GB, Coon CC, Benbow U, Vincenti MP, Brinckerhoff CE, (2002) Erk 1/2 differentially regulates the expression from the 1G/2G single nucleotide polymorphism in the MMP-1 promoter in melanoma cells. Biochim Biophys Acta 1586: 265-274.
36. Kanamori Y, Matsushima M, Minaguchi T, Kobayashi K, Sagae S, et al. (1999) Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 59: 4225-4227.
37. Zhu Y, Spitz MR, Lei L, Mills GB, Wu X, (2001) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 61: 7825-7829.
38. Ghilardi G, Biondi ML, Mangoni J, Leviti S, DeMonti M, et al. (2001) Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res 7: 2344-2346.
39. Vairaktaris E, Yapijakis C, Derka S, Serefoglou Z, Vassiliou S, et al. (2007) Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma. Anticancer Res 27: 459-464.
40. Benbow U, Tower GB, Wyatt CA, Buttice G, Brinckerhoff CE, (2002) High levels of MMP-1 expression in the absence of the 2G single nucleotide polymorphism is mediated by p38 and ERK1/2 mitogen-activated protein kinases in VMM5 melanoma cells. J Cell Biochem 86: 307-319.
41. Eickelberg O, Kohler E, Reichenberger F, Bertschin S, Woodtli T, et al. (1999) Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. Am J Physiol 276: L814-824.
42. Pardo A, Selman M, (2005) MMP-1: the elder of the family. Int J Biochem Cell Biol 37: 283-288.
43. Fineschi S, Reith W, Guerne PA, Dayer JM, Chizzolini C, (2006) Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblasts. Faseb J 20: 562-564.
44. Yamamoto T, Eckes B, Mauch C, Hartmann K, Krieg T, (2000) Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop. J Immunol 164: 6174-6179.